Key facts
- Terraflos’s last known valuation is $62.0M (Aug 2021).
- It has raised $14.0M; the latest was Early Stage VC in Dec 2026.
- Notable investors include Acelerar España, Alejandro Dillon, Camilo Villalba, FL Ventures, Facundo Belocopitt — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Terraflos
- ·The full record, as it builds
Funding rounds
No funding rounds for Terraflos are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Terraflos
Developer of a consumer science platform that integrates biotechnology, AI, and branded products designed to create bioactives that support health, wellness, and longevity. The company offers vertically integrated R&D, manufacturing, and commercialization capabilities across supplements, functional foods, and skincare, enabling health-conscious consumers to access sustainable, high-quality, science-backed products.
- Sector
- Healthcare
- HQ
- Road Town, British Virgin Islands
- Founded
- 2021
- Employees
- 90
- Website
- terraflos.com/
- Ownership
- Privately Held (backing)
Terraflos doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Terraflos shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Terraflos in its N-PORT filings yet. We sweep new filings monthly.